1. The Commission shall be assisted by the Standing Committee on Medicinal Products for Human Use set up established by Article 121 of Directive 2001/83/EC and by the Standing Committee on Veterinary Medicinal Products set up by Article 89 of Directive 2001/82/EC.
2. Where reference is made to this paragraph, Articles 5 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
The period laid . That committee shall be a committee within the meaning of Regulation (EU) No 182/2011 of the European Parliament and of the Council [Regulation (EU) No 182/2011 of the European Parliament and of the Council of 16 February 2011 laying down in Article 5(6) of Decision 1999/468/EC shall be set at three months.
2a. Where reference is made to this paragraph, Article 5a(1) to (4) and Article 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
3the rules and general principles concerning mechanisms for control by Member States of the Commission’s exercise of implementing powers (OJ L 55, 28.2.2011, p. 13).].
2. Where reference is made to this paragraph, Articles 4 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
The period laid down in Article 4(3) of Decision 1999/468/ECArticle 5 of Regulation (EU) No 182/2011 shall be set at one month.
4. The committees shall adopt their Rules of Procedure.apply.